Podcasts about Molecule

Butyrate is a short-chain fatty acid (SCFA) produced by gut bacteria that ferment dietary fiber. It serves as essential fuel for colon cells and maintaining overall systemic health Adequate fiber intake — around 30 grams daily — is crucial for butyrate production. Without it, your body burns stored fat and protein, creating disease-causing byproducts Butyrate strengthens your gut barrier, preventing intestinal permeability that allows harmful substances to enter the bloodstream and trigger autoimmune responses Research shows butyrate improves insulin sensitivity, reduces diabetes risk, lowers bad cholesterol, prevents colorectal cancer, and supports brain health Boost butyrate by eating fiber-rich foods, resistant starches, fermented foods and probiotics, while avoiding processed foods, managing stress, and limiting unnecessary antibiotics

In this episode of Healthy Mind, Healthy Life, host Yusuf sits down with Larry Kesslin, author of The Joy Molecule, to unpack why joy is not something you chase, it's something you align with. Larry shares how a 2012 trip to rural Uganda reshaped his beliefs about success, purpose, and what truly creates a meaningful life. This conversation is for anyone who looks “fine” on the outside but feels disconnected inside. You'll learn Larry's practical framework for inner peace, how misalignment shows up as stress and constant seeking, and why joy is an inward journey that leads to deeper connection. About the Guest: Larry Kesslin is the author of The Joy Molecule and Success Redefined. He coaches individuals and supports companies in building ecosystems and communities rooted in connection. Key Takeaways: Define happiness vs. joy clearly: needs met vs. inner peace Use “what, who, why” to check alignment before chasing goals Watch for stress and “everything is happening to me” as misalignment signals Detach from identity labels to reduce suffering and regain clarity Follow “breadcrumbs” by doing the next best logical step, right now How to Connect With the Guest: Website: https://www.5-dots.com/  Email: https://www.podmatch.com/hostdetailpreview/avik Disclaimer: This video is for educational and informational purposes only. The views expressed are the personal opinions of the guest and do not reflect the views of the host or Healthy Mind By Avik™️. We do not intend to harm, defame, or discredit any person, organization, brand, product, country, or profession mentioned. All third-party media used remain the property of their respective owners and are used under fair use for informational purposes. By watching, you acknowledge and accept this disclaimer. Healthy Mind By Avik™️ is a global platform redefining mental health as a necessity, not a luxury. Born during the pandemic, it's become a sanctuary for healing, growth, and mindful living. Hosted by Avik Chakraborty, storyteller, survivor, and wellness advocate. With over 6000+ episodes and 200K+ global listeners, we unite voices, break stigma, and build a world where every story matters.

Micah Hanks joins us again tonight for a conversation that starts out about Giants, but meanders all over the place, from the Nephilim, to Lost Civilizations, to much, much more. This one also runs a bit long, clocking in around an hour and a half.Micah Hanks is a writer, researcher, lecturer, and radio personality whose work addresses a variety of scientific concepts and unexplained phenomena. Over the last decade, his research has examined a variety of approaches to studying the unexplained, cultural phenomena, human history, and the prospects of our technological future as a species as influenced by science.He is author of several books, including Magic, Mysticism and the Molecule,Reynolds Mansion: An Invitation to the Past, and his 2012 New Page Books release, The UFO Singularity. Hanks is an executive editor of Intrepid Magazine, and consulting editor/contributor for FATE Magazine and The Journal of Anomalous Sciences. He also writes for a variety of other publications including UFO Magazine, Mysterious Universe, and New Dawn. Hanks has appeared on numerous TV and radio programs, including Coast to Coast AM with George Noory, Whitley Strieber's Dreamland, National Geographic's Paranatural, the History Channel's Guts and Bolts, CNN Radio, The Jeff Rense Program, and many others. A weekly podcast that follows his research is available at his popular Website, www.gralienreport.com. Hanks lives in the heart of Appalachia near Asheville, North Carolina. For everything Micah does, go to www.MicahHanks.com. Hosted on Acast. See acast.com/privacy for more information.

Send us a textDr. Brandon Crawford is joined by Samuel Shepherd, a former Department of Defense biochemical engineer who used his expertise in weapons development to reverse-engineer a cure for his own "incurable" bone cancer. They deep-dive into the science of oxidative stress, the hierarchy of antioxidants, and the specific molecule that allows animals like naked mole rats and sharks to resist cancer and aging.Samuel recounts his 2003 diagnosis of polycythemia vera, where his blood pressure reached levels that "pegged" medical monitors at 300 mmHg. After years of grueling phlebotomies, Sam used a screening algorithm to find a commonality among cancer-resistant species. That common thread was Astaxanthin. However, he didn't just find a supplement; he discovered a way to modify the molecule into a glucosidic form that bypasses the body's digestive barriers to target disease at the atomic level.Key TakeawaysThe Root of All Evil: 92% of inflammatory disease deaths are driven by the hydroxyl free radical. By neutralizing this specific ROS, you address the cause of disease (the trunk) rather than just the symptoms.Molecular Saponification: By using a glucosidic "Trojan Horse" delivery, astaxanthin enters cancer cells and converts acidic free radicals into alkaline ions, dissolving the cancer cell membrane in seconds.The Antioxidant Cliff: Natural cellular protection (Glutathione, SOD) fails significantly after age 42 W or 50 M, making external supplementation essential for longevity.Beyond Brain Barriers: Unlike many antioxidants, this specialized form of astaxanthin crosses the blood-brain barrier, allowing it to neutralize neurotoxins linked to Parkinson's and Alzheimer's.ResourcesUse code CRAWFORD at checkout on Valasta.net for a discount on your order.Valasta.net (testimonials, NIH research papers, dosing information)NIH Research Database (search: "NIH + astaxanthin + [disease]")ProQuest Government Research DatabaseLife Extension (publishes astaxanthin research papers)Dr. Fred Bisci (mentioned as colleague)HSCRP (high-sensitivity C-reactive protein) testing for inflammation markersHematococcus Pluvialis (algae source of astaxanthin)Products 528 Innovations Lasers NeuroSolution Full Spectrum CBD NeuroSolution Broad Spectrum CBD NeuroSolution Stimpod STEMREGEN® Learn MoreFor more information, resources, and podcast episodes, visit https://tinyurl.com/3ppwdfpm

In this episode of Molecule to Market, you'll go inside the outsourcing space of the global drug development sector with 20+ CEO/c-suite leaders from the CDMO space, who discuss the optimism levels for the pharmaceutical and biotechnology space for 2026.   Guests include: Christiane Bardroff, Chief Operating Officer (COO) at Rentschler Biopharma SE Philip Macnabb, Chief Executive Officer at Curia Kaan-Fabian Kekec, Partner at Simon-Kucher‘s Healthcare & Life Sciences division Dirk T. Lange , Chief Executive Officer at Pyramid Pharma Services Bruce Thompson, CTO at Kincell Bio Bill Vincent, Biotech Entrepreneur, CEO, Board Member Derek Hennecke - founder, investor, board member Matthew Bio, CSO at Cambrex & President, Snapdragon Chemistry Stephen Dilly, CEO at Sonoma Biotherapeutics, Bill Humphries, Chief Executive Officer at Medpharm Elisabeth Stampa, CEO at Medichem SL Philip Lee, CEO at GeneFab Kerstin Dolph, SVP of Manufacturing at Charles River Labs Eric Edwards, Chief Executive Officer at Phlow-USA Peter DeYoung, CEO at Piramal Pharma Ian Tzeng, Managing Director at L.E.K. Consulting Adam Siebert, Managing Director at L.E.K. Consulting J.D. Mowery, President CDMO Division Bora Pharmaceuticals Peter Belden President, US, Tjoapack   Molecule to Market is also sponsored by Bora Pharmaceuticals and Charles River Laboratories, and supported by Lead Candidate. Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We'd also appreciate a positive rating!

What if everything you thought about success and happiness was missing one crucial element? For Larry Kesslin, the answer came during a life-changing trip to rural villages in Africa in 2012. While he went there to bring computers, he discovered something far more profound: people living with joy, connection, and purpose—despite having very little in material wealth.In this episode, Larry shares how that journey inspired the creation of The Joy Molecule, a framework that helps people uncover their What, Who, and Why—their gifts, values, and purpose. Tune in to discover:How a trip to Africa reshaped Larry's view of successWhy successful people often feel unhappyThe three elements of the Joy Molecule and why they matterThe hidden costs of chasing success without purposeSteps to rediscover joy, purpose, and connectionEpisode Resources:⁠⁠⁠⁠Larry Website: https://5-dots.com/Larry Book: https://thejoymolecule.com/Larry LinkedIn: https://www.linkedin.com/in/larrykesslin/

Butyrate is a short-chain fatty acid (SCFA) produced when gut bacteria ferment dietary fiber. It provides energy for colon cells and offers health benefits beyond basic nutrition Research suggests butyrate helps manage inflammatory bowel disease (IBD) by reducing inflammation, improving symptoms and strengthening gut barrier integrity Laboratory studies show butyrate helps inhibit cancer cell growth and trigger cell death in colorectal cancer cells, with clinical trials exploring its use alongside traditional treatments Butyrate has been shown to improve insulin sensitivity and glucose metabolism in metabolic disorders, while also influencing appetite-regulating hormones Studies show butyrate protects against neurodegenerative diseases by reducing brain inflammation and enhancing neuronal repair and survival

In this episode of Molecule to Market, you'll go inside the outsourcing space of the global drug development sector with Selin Kurnaz,  Co-Founder and CEO at Massive Bio,   Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Selin, covering:   How a cancer diagnosis in her family led Selin down a path of accidental entrepreneurship, fundraising, and the application of AI in drug development. The major pivots in Massive Bio's journey that transformed it into a broker of access between patients and pharmaceutical companies. Her views on the misallocation of capital in market access enablers versus research and development. How gaining traction with advocates inside big pharma helped ensure investors took notice. Why the influence of AI on clinical trials and real world evidence will continue to grow as part of the patient journey.   Selin Kurnaz graduated from Boğaziçi University in Turkey, where she had a dual major in industrial engineering and mechanical engineering. She then continued her education in the United States, where she obtained two masters degrees and a doctorate in mechanical engineering at the University of Michigan. Following her education, Selin served as an executive consultant on strategy, operations, and company trading for a decade. In 2015, she co-founded Massive Bio.     Molecule to Market is also sponsored by Bora Pharmaceuticals and Charles River Laboratories, and supported by Lead Candidate. Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We'd also appreciate a positive rating!

Send us a textUnlock Proven Strategies for a Lucrative Business Exit—Subscribe to The Deep Wealth Podcast TodayHave Questions About Growing Profits And Maximizing Your Business Exit? Submit Them Here, and We'll Answer Them on the Podcast!“Be careful whom you trust.”- Nathan BryanExclusive Insights from This Week's EpisodesDr. Nathan S. Bryan, billion-dollar founder and nitric oxide pioneer, delivers the no-BS blueprint to reclaim control. You'll gain insider strategies to boost blood flow, reverse disease markers, and fuel unbreakable stamina for your entrepreneurial grind. 00:05 The journey from poverty to building billion-dollar companies00:08 Why nitric oxide is the master regulator of human health00:11 How modern diets and mouthwash destroy nitric oxide production00:16 The early warning signs your body is failing long before disease00:20 Why beets and popular nitric oxide supplements do not work00:25 How nitric oxide impacts energy, sexual health, and cognition00:30 The daily rituals Dr. Bryan uses to stay at peak performance00:33 Battling Big Pharma and refusing massive acquisition offers00:40 Why money is a consequence, not the missionClick here for full show notes, transcript, and resources:https://podcast.deepwealth.com/505Essential Resources to Maximize Your Business ExitLearn More About Deep Wealth MasteryFREE Deep Wealth eBook on Why You Suck At Selling Your Business And What You Can Do About It (Today)Book Your FREE Deep Wealth Strategy CallUnlock Your Lucrative Exit and Secure Your Legacy

En este episodio especial de cierre y comienzo de año, Lucas y Cristóbal comparten sus libros favoritos del año y usan esas lecturas como excusa para reflexionar sobre atención, dopamina, AI, creatividad, genios obsesivos, tecnología, poder y cómo leemos (y pensamos) en un mundo cada vez más ruidoso. __Muchas gracias a nuestro Sponsor, Analytics Town por apoyar este episodio!¿Quieres crear un producto basado en inteligencia artificial pero no sabes por dónde empezar?En Analytics Town te ayudamos a diseñar tu nuevo producto y modelo de negocio, desde la estrategia hasta la ejecución del software con módulos de IA.Descubrimos oportunidades para tu empresa y validamos tu idea.Armamos el diseño funcional y el modelo de negocio.Diseñamos y desarrollamos tu producto potenciado con Inteligencia Artificial.Te acompañamos en todo el proceso, desde la idea hasta convertirlo en negocio rentable...Si mencionas que vienes de Indie vs Unicornio, te llevas el primer diagnóstico gratis!

In this episode of Molecule to Market, you'll go inside the outsourcing space of the global drug development sector with Jim Gale, Founding Partner & Managing Director at Signet.   Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Jim, covering: The origins of growth equity in private equity and how it led to the founding of Signet, a fund built on deep domain expertise. Why private equity is a growing asset category but still remains undervalued and under appreciated. How the nature of the companies Signet invests in has evolved over the last twenty five years, while the fundamental principles of building a strong business remain the same. How the “picks and shovels” strategy of investing in tools, services and infrastructure has consistently served them well. Jim's assessment criteria when evaluating new opportunities after seventy deals, including the key question… can we institutionalise an entrepreneur led business. How higher interest rates and economic uncertainty constrain biopharma and biotech, and how that impacts investment dollars flowing into pharma services, along with deal flow, valuation and structure. James “Jim” Gale is the Founding Partner and Managing Director of Signet Healthcare Partners, a New York based healthcare growth equity firm specialising in pharmaceutical services, specialty pharma and medical technology. With more than thirty five years of investing and finance experience, Jim has built a deep track record backing companies involved in formulation, development, manufacturing and commercialisation across the world.   At Signet, Jim has led investments across the pharma services value chain, including platforms in sterile fill finish, complex formulations, biologics development and specialty generics. His current and recent board roles include Ascendia Pharmaceutical Solutions, NorthX Biologics, RK Pharma, Bionpharma, Chr Olesen Synthesis, Pharma Nobis, Juno Pharmaceuticals and Lee's Pharmaceutical. He also serves as Chairman of Bionpharma and is a director of Knight Therapeutics.   Jim holds an MBA from the University of Chicago Booth School of Business.   Molecule to Market is also sponsored by Bora Pharmaceuticals and Charles River Laboratories, and supported by Lead Candidate. Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We'd also appreciate a positive rating!

Chris Burres has spent years diving into the molecular science of aging, enabling him to create groundbreaking products with the potential to double people's lifespans. He joins Corinna Bellizzi to share how he and his team at MyVitalC have created a special blend of the molecule ESS60 in organic extra virgin olive oil to improve human longevity like never before. He explains how it influences oxidative stress, mitochondrial function, and overall cellular resilience, leading to healthier and more vibrant lives. Chris also talks about the Buffering Oxidative Stress System or BOSS Theory that explains how the molecule ESS60 works, the importance of further scientific research on this matter, and how improv comedy greatly shaped his professional life. About Guest: Chris Burres is the founder and chief scientist at MyVitalC, where he manufactured a Nobel Prize-winning molecule responsible for the single longest longevity experimental result in history–a full 90% extension of life. He is also a published author, host of the Uncovering the Secrets to Longevity Health Summit, a podcast host, patent holder and master of comedy improv. He is the intersection where science meets laughter and his life's mission is to help people live longer, healthier, happier, pain-free lives with science. Guest LinkedIn: https://www.linkedin.com/in/chrisburres Guest Website: https://www.myvitalc.com/ Guest Social:  https://www.youtube.com/@MyVitalC/videos https://www.tiktok.com/@myvitalc https://www.instagram.com/myvitalc https://www.facebook.com/myvitalc Show Notes: Raw audio FV [04:39] How Chris Got Involved In Longevity Research [08:48] Seeing Supplements As Highly Regulated Foods [11:36] Possibility Of Extending Mammal Life Up To 90% [18:57] The Process Of Creating And Manufacturing ESS60 [21:39] Understanding The Buffering Oxidative Stress System (BOSS) Theory [24:47] Importance Of Scientific Research (And Why Many Refuse To Do It) [30:28] How ESS60 Is Delivered To The Consumers [36:54] What Does Sensitivity C-Reactive Protein (hs-CRP) Says About Your Body [47:37] Paying More Attention To Health Span Than Lifespan [54:07] The High Costs And High Rewards Of Scientific Research [56:58] A Humorous Example Of The BOSS Theory [58:30] Valuable Lessons From Improv And Stand-Up Comedy [01:01:09] The Mindset You Need To Achieve A Healthier You [01:04:40] A Special Offer From Chris BUILD A GREENER FUTURE with CARE MORE BE BETTER Together, we planted 36,044 trees in 2025 through our partnership with ForestPlanet. We screamed past our goal of planting 20,000 trees thanks to subscribers like you! NEW CAUSE PARTNER FOR 2025-2026 SELECTED! If you value open dialogue, sustainability, and social equity, I invite you to support our new cause partner — Prescott College. To learn more about this effort and to support the show, visit: https://caremorebebetter.com/support/ Follow us on social media: YouTube:https://www.youtube.com/c/caremorebebetter TikTok: https://www.tiktok.com/@caremorebebetter Instagram: https://www.instagram.com/caremorebebetter Facebook: https://www.facebook.com/CareMoreBeBetter LinkedIn: https://www.linkedin.com/company/care-more-be-better Blog Post URL https://caremorebebetter.com/how-molecule-ess60-improves-human-longevity-with-chris-burres/ Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

As we draw close to the end of 2025, our host Raman Sehgal talks about the top 5 episodes of the year.   Molecule to Market is also sponsored by Bora Pharmaceuticals and Charles River Laboratories, and supported by Lead Candidate. Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We'd also appreciate a positive rating!

In this episode of the Let's Go Win Podcast, JM sits down with Dr. Nathan Bryan, one of the world's leading experts on nitric oxide, to unpack why this tiny gas molecule may be the most overlooked driver of long term health, performance, and aging. Discovered as a signaling molecule only a few decades ago and recognized with a Nobel Prize, nitric oxide quietly regulates blood flow, inflammation, mitochondrial function, and immune balance. Dr. Bryan explains why the loss of nitric oxide production is now considered the earliest event in many chronic diseases, including heart disease, diabetes, neurodegeneration, autoimmune conditions, and poor wound healing. Together, they explore what destroys nitric oxide in modern life, what daily habits restore it, and how small changes in breathing, diet, oral care, movement, and sleep can create outsized improvements in energy, cognition, vascular health, and recovery. Key takeaways: Why nitric oxide is a root level regulator of cardiovascular, metabolic, immune, and mitochondrial health How reduced nitric oxide production is linked to nearly every age related chronic diseaseThe surprising role of the oral microbiome in nitric oxide production and systemic health Why antiseptic mouthwash, excess sugar, fluoride exposure, and chronic antacid use can sabotage nitric oxide pathways How nasal breathing directly increases nitric oxide and improves oxygen delivery The impact of intermittent fasting and blood sugar control on vascular and mitochondrial function Which daily habits reliably stimulate nitric oxide production through natural mechanisms What to know about beet products, supplements, and nitric oxide delivery methods that actually work How restoring nitric oxide can translate into better blood pressure, energy, sleep, healing, and cognitive clarity Why lifestyle based nitric oxide support may outperform many pharmaceutical approaches for prevention and longevity This episode is for anyone who cares about aging well, preventing chronic disease, improving performance, or taking ownership of their health beyond symptom chasing. If you are a high performer dealing with fatigue, inflammation, poor recovery, brain fog, blood pressure issues, or metabolic challenges, this conversation will give you a new lens on what might be missing. You will walk away with a practical checklist you can apply immediately, a deeper understanding of how your daily habits either block or support your body's natural healing systems, and a science backed framework for improving health from the ground up. This is not about biohacking trends. It is about restoring a fundamental biological signal your body depends on to thrive. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

115. 5-MeO-DMT Experience ExplainedA grounded conversation on the 5-MeO-DMT experience—how it affects the nervous system, how it differs from DMT, and why safety and integration matter.Episode SummaryWhat is 5-MeO-DMT, and why do people describe it so differently from other psychedelics?In this episode, April Pride sits down with licensed clinicians and facilitators Roger and Dustin to explore the 5-MeO-DMT experience through both lived experience and emerging neuroscience. Often referred to as the God molecule psychedelic, 5-MeO-DMT is widely described as a non-visual psychedelic experience—one that quiets the nervous system rather than amplifying imagery, stories, or symbols.Together, they break down 5-MeO-DMT vs DMT, explain how this compound interacts with serotonin receptors in the brain, and discuss why many people report profound ego dissolution, nervous system regulation, and long-term shifts in how they experience safety and connection.This episode also centers women and psychedelics, examining why women—particularly those who have spent years in control, caretaking, or emotional labor—may feel especially drawn to this form of surrender-based medicine.If you're seeking grounded insight into psychedelic harm reduction, integration after 5-MeO-DMT, and what makes this medicine fundamentally different from other psychedelic experiences, this conversation is an essential listen.

This week, UCLA WBB star Lauren Betts joins Bob to talk about her winning the 2025 Naismith Defensive Player of the Year Award, presented by MOLECULE! Bob highlights the key games for the men and women on our news and notes feature, presented by Jersey Mike's! WANT TO SUPPORT A TROPHY LIFE?Leave a rating and review on iTunes, Spotify, or wherever you get your podcasts. Your feedback only helps make the show better, and we appreciate your support! For more information about the Naismith Trophy Award, visit our home on the web.

In this episode of Molecule to Market, you'll go inside the outsourcing space of the global drug development sector with Thomas Dobmeyer, medical, entrepreneur and investor at ekwithree.   Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Thomas, covering: Choosing to freelance and consult as a medic after qualifying in medicine. Co-founding a niche regulatory affairs firm and growing it into a 3,000-person multinational pharmaceutical solutions organisation. Expanding into new countries, acquisitions, and domains to build scale and credibility in biopharma — with culture as the secret weapon. Why lawmakers and regulators became his best salespeople, and how increasing complexity, internationalisation, and market growth ultimately led to a $1.4B exit to Cencora. Life after the sale as an active investor and mentor — and the key trends Thomas sees shaping the future of drug development. Dr. Thomas Dobmeyer is a physician, researcher, and entrepreneur currently serving as a partner at ekwithree GmbH, a growth investment firm specializing in technology-driven B2B service providers. In this role, Thomas plays a key part in driving the organizational success of ekwithree and its diverse portfolio of companies.   With over two decades of extensive experience in the pharmaceutical and medical technology industries, Thomas was founder and CEO of PharmaLex GmbH. There, he spearheaded the transformation of a startup consulting boutique into a globally recognized unicorn company operating in 40 countries with 3,500 employees. His strategic expertise was instrumental in shaping and executing the company's business strategies, overseeing leadership team formation, advising on strategic matters, and ensuring the implementation of robust business plans to achieve corporate objectives. Under his leadership, PharmaLex successfully completed nearly 40 mergers and acquisitions, significantly expanding its global business model and footprint.   Molecule to Market is also sponsored by Bora Pharmaceuticals and Charles River Laboratories, and supported by Lead Candidate. Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We'd also appreciate a positive rating!

This episode, University of Edinburgh PhD candidate Mia Belle Parkinson chats with Dr Paul Rimmer from the University of Cambridge. We talk about what "Experimental Astrophysics" is, what happened after the discovery of phosphene on Venus, and where we might find alien life first (Venus? In our solar system? On exoplanets?).

In this episode of Molecule to Market, you'll go inside the outsourcing space of the global drug development sector with our host Raman Sehgal. Raman distils dozens of executive conversations across 2025 into three key insights you can take into 2026 for you and your organization.    Molecule to Market is also sponsored by Bora Pharmaceuticals and Charles River Laboratories, and supported by Lead Candidate. Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We'd also appreciate a positive rating!

ORIGINAL AIR DATE: NOV 20, 2013MICAH HANKS is a writer and researcher whose work addresses a variety of unexplained phenomena. Over the last decade, his research has taken him into studies of military history, spirituality, sociology and cultural phenomena, humanity's origins, and the prospects of our technological future as a species as influenced by science. He is the author of a number of books, including The UFO Singularity, Magic, Mysticism and the Molecule and Reynolds Mansion: An Invitation to the Past. Hanks also writes for several magazines and other publications such as FATE, UFO Magazine, The Journal of Anomalous Sciences, Intrepid Magazine and New Dawn. He has also appeared on a number of TV and radio programs, including National Geographic's Paranatural, the History Channel's Guts and Bolts, CNN Radio, The Jeff Rense Program and Coast to Coast AM with George Noory. With nearly a decade in the broadcasting industry, Hanks also hosts The Micah Hanks Radio Program on KGRA out of Kansas City, and produces a weekly podcast called The Gralien Report that follows his research. You can learn more about his writing and interests at his Websites, gralienreport.com and micahhanks.com. Hanks lives in the heart of Appalachia near Asheville, North Carolina.BRUCE COLLINS is a former pro wrestling promoter, an author of three published books (one of them with Brett Wagner, the host of The Speed Channel's PASS TIME and voice of Monster Garage and another book with Ric Drasin, the middle Hulk in the 1970's Incredible Hulk tv show with Bill Bixby and the creator of the Gold's Gym logo) and the former book reviewer of Monster Radio, which was nationally syndicated in 84 radio markets. Bruce has hosted The Bruce Collins Show (and its' genesis known as The Big Finale) since January, 2006. The Bruce Collins Show graduated to AM radio in 2009 and spent two years broadcasting at WSMN 1590 AM in Nashua, New Hampshire and WWZN 1510 AM in Boston, MA. Currently, the program resides online at www.fringeradionetwork.com . Based on the AM radio exposure, he was approached by the History Channel's Decoded TV (with bestselling author Brad Meltzer) to audition for their program. After learning he would have to interview occultists and numerologists without expressing his own opinions, he turned down the invitation. Bruce is the self-proclaimed Baron of Broadcasting.CHAD MILES is the co-host of The Bruce Collins Show. He is also a former contributing editor for Defense Watch Magazine and former contributor to The Michigan Journal. In 2006 Chad ran for a seat in the U.S. House of Representatives in Michigan's 14th Congressional District. He served seven years on active duty with the 82nd Airborne Division, 2nd Infantry Division and the 5th Special Forces Group. His Military service as an infantryman and intelligence analyst took him around the world with service in the countries of Jordan, Egypt, South Korea and Panama.  Chad is a member of the Veterans of Foreign Wars and the American Legion. He was the creator and founder of the wildly popular Hearken the Watchmen website which featured articles from Chuck Missler, L.A. Marzulli, Michael Hoggard and many others. Miles appeared on Coast to Coast AM with George Noory to talk about drones over Miami, Florida. Chad is known as “The Odometer” and “Captain Doomsday.”

If you've tried every longevity hack and still feel like something's missing, this episode is for you! The Nobel Prize-winning molecule ESS60 could be the breakthrough you've been searching for.  In this episode, Chris Burres, founder and chief scientist at My Vital C, unpacks how a molecule once used only for industrial purposes is now making headlines for extending life and optimizing health. If you're curious about simple ways to boost your energy, sleep better, and feel younger, you'll want to hear how this overlooked discovery is changing lives. Listen to this episode and unlock your potential for a longer, healthier future! For show notes, visit https://fivejourneys.com/podcasts/how-you-could-live-longer-with-this-nobel-prize-winning-molecule/  Follow us on Instagram at https://www.instagram.com/feelfreakingamazing/  Related Episodes: Unlocking Longevity: Transform Your Health with a Fasting Mimicking Diet, with Dr. Joseph Antoun Longevity and mTOR: What the Science Says, with Dr. Robert Lufkin Live Longer & Reverse Aging, with Dr. Kara Fitzgerald Aging with Vitality and Strength, with Dr. Sandra Scheinbaum Reversing Aging: The Power of NAD+, with Dr. Nichola Conlon Hormones for Healthy Aging, with Dr. Daved Rosensweet Slow Aging by Optimizing These Redox Reactions, with Dr. Monisha Bhanote

In this episode, our guest is Massimiliano Cervo, who shares clear and practical insights on how the Middle East is approaching the energy transition. He discusses the growing role of renewables, the importance of balancing the energy trilemma, and why diversification—not a single technology—is key. Massimiliano also breaks down where hydrogen truly makes economic sense and how policy, carbon pricing, and mandates will shape future energy systems. Please join to find more: Connect with Sohail Hasnie: Facebook @sohailhasnie X (Twitter) @shasnie LinkedIn @shasnie ADB Blog Sohail Hasnie YouTube @energypreneurs Instagram @energypreneurs Tiktok @energypreneurs Spotify Video @energypreneurs

Use code COOLWORLDS at https://novium.shop/coolworlds to get an exclusive 15% off for the next 72 hours. In this week's episode, David is joined by Néstor Espinoza - Associate Astronomer and Mission Scientist of Exoplanet Science at the Space Telescope Science Institute in Baltimore. Néstor is a prolific researcher, developing state-of-the-art statistical tools and performing some of the most exciting analyses of exoplanets with JWST. To support this podcast and our research lab, head to https://coolworldslab.com/support Cool Worlds Podcast Theme by Hill [https://open.spotify.com/artist/1hdkvBtRdOW4SPsnxCXOjK]

In this episode of Molecule to Market, you'll go inside the outsourcing space of the global drug development sector with Nick Fortin, Chief Executive Officer at Codis. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Nick, covering: Nick's desire to scratch that entrepreneurial itch, while recognising he was missing a key tool in his toolbox, which led him to pursue a midlife MBA. His turnaround role at Neopharma exposed him to major players in the pharma services space, ultimately paving the way to Particle Dynamics (now Codis). The major pillars Nick established when he joined Particle Dynamics as CEO, and the company's transformational journey that led to further investment, a major international acquisition, and the creation of Codis. Key lessons on managing multiple investors around the board table — and the critical role of a Chairman. Why the bioavailability challenge for many molecules in the pipeline supports continued growth in spray drying. Nicolas joined Particle Dynamics as President and CEO in 2018. He has almost 30 years of experience in the pharmaceutical industry across multiple leadership roles. Nicolas earned a Bachelor's degree in Engineering and holds an MBA from McGill and HEC Universities. Molecule to Market is sponsored by Bora Pharma (boracdmo.com) and Charles River (criver.com), and supported by Lead Candidate. Please subscribe, share with your industry colleagues, and join us in celebrating and promoting the value of the global life sciences outsourcing space. We'd also appreciate a positive rating!

Please visit answersincme.com/860/99505211-replay2 to participate, download slides and supporting materials, complete the post test, and get a certificate. In this activity, experts in psoriasis discuss real‑world strategies for using oral small molecules in moderate to severe disease. Upon completion of this activity, participants should be better able to: Identify patients with moderate to severe plaque psoriasis who would benefit from oral small molecule therapy; Differentiate the targets/mechanisms of action of available oral small molecule therapy for moderate to severe plaque psoriasis; and Integrate strategies to individualize oral small molecule therapy for moderate to severe plaque psoriasis, while balancing safety, considering regional barriers.

Please visit answersincme.com/860/99505211-replay2 to participate, download slides and supporting materials, complete the post test, and get a certificate. In this activity, experts in psoriasis discuss real‑world strategies for using oral small molecules in moderate to severe disease. Upon completion of this activity, participants should be better able to: Identify patients with moderate to severe plaque psoriasis who would benefit from oral small molecule therapy; Differentiate the targets/mechanisms of action of available oral small molecule therapy for moderate to severe plaque psoriasis; and Integrate strategies to individualize oral small molecule therapy for moderate to severe plaque psoriasis, while balancing safety, considering regional barriers.

The FDA Group's Nick Capman sits down with Carlos Carrillo, PhD, MSc, Senior Vice President of Regulatory Affairs & Quality Assurance at SAB Biotherapeutics. With nearly 30 years of experience across Operations, R&D, Regulatory Affairs, Quality Assurance, and Project Management, Carlos has led global regulatory strategy for small- and large-molecule programs from Phase 1 through launch. He has prepared IND/IMPD/CTA/CTR/BLA/MAA submissions across multiple regions, secured expedited designations, managed FDA and ex-US health authority meetings, and built RA/QA systems for growing biotech organizations.Carlos shares practical, experience-tested guidance on how small and mid-size biotech companies can build regulatory resilience: strengthening governance, preparing for FDA interactions, improving documentation discipline, and integrating external partners without losing control. He also breaks down how to evaluate vendors, structure joint governance, embed QA into outsourced workflows, and design audit-ready data flows that prevent institutional knowledge loss.Topics discussed include:Why early regulatory infrastructure prevents costly reworkLeadership behaviors that shape regulatory cultureHow to prepare for high-stakes FDA and ex-US health authority meetingsThe risks of “tribal knowledge” in fast-moving organizationsA structured model for evaluating and managing external partnersHow small companies can stay inspection-ready with lean teamsOne takeaway: External partners can be force multipliers or liabilities—the sponsor's structure and oversight determine which.About The FDA Group:The FDA Group helps life science organizations rapidly access the industry's best consultants, contractors, and candidates. Our resources assist in every stage of the product lifecycle—from clinical development to commercialization—with a focus on staff augmentation, auditing, remediation, QMS, and specialized project work in Quality Assurance, Regulatory Affairs, and Clinical Operations.https://www.thefdagroup.com/

We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Dan Schmitt, President and CEO at Actuate Therapeutics, talks about building a company around elraglusib, a GSK-3β inhibitor for cancer. Dan describes his fast-fail approach to early product testing and development, using basket trials to evaluate chemotherapy combinations, and choosing pancreatic cancer as a lead program. He also talks about surviving an IPO during a brutal funding cycle for biotech, building lean teams and efficient operations, and potentially onshoring API in response to changing U.S. policy. Access this and hundreds of episodes of the Business of Biotech videocast under the Business of Biotech tab at lifescienceleader.com. Subscribe to our monthly Business of Biotech newsletter. Get in touch with guest and topic suggestions: ben.comer@lifescienceleader.comFind Ben Comer on LinkedIn: https://www.linkedin.com/in/bencomer/

Dr. Andrew Salzman is a Harvard-educated physician, inventor, and biomedical entrepreneur with more than 30 years of experience in drug discovery and development, Dr. Salzman has published over 170 clinical studies, been cited in more than 12,000 peer-reviewed papers, and obtained over 50 patents. His invention of an NAD-activated DNA repair mechanism led to the world's first clinical treatment for ovarian and breast cancer caused by BRCA gene mutations. Today on the show we discuss: why energy declines as you age and what actually causes it, how a single molecule impacts aging and cognition, the real role of diet and exercise in cellular health, why inflammation may be the true driver of aging, the truth about NAD drips and supplementation, and what matters most if you want to live longer and perform better. Learn more about Wonderfeel: Subscribe and get 15% off Website Try Wonderfeel Youngr™ NMN Instagram ⚠ WELLNESS DISCLAIMER ⚠ Please be advised; the topics related to mental health in my content are for informational, discussion, and entertainment purposes only. The content is not intended to be a substitute for professional advice, diagnosis, or treatment. Always seek the advice of your mental health professional or other qualified health provider with any questions you may have regarding your current condition. Never disregard professional advice or delay in seeking it because of something you have heard from your favorite creator, on social media, or shared within content you've consumed. The Adversity Advantage podcast does not endorse or support the claims or opinions of any guests and strongly encourages all viewers and listeners to do their own due diligence before buying products or supporting brands discussed by guests on the show.  If you are in crisis or you think you may have an emergency, call your doctor or 911 immediately. If you do not have a health professional who is able to assist you, use these resources to find help: Emergency Medical Services—911 If the situation is potentially life-threatening, get immediate emergency assistance by calling 911, available 24 hours a day. National Suicide Prevention Lifeline, 1-800-273-TALK (8255) or https://suicidepreventionlifeline.org.  SAMHSA addiction and mental health treatment Referral Helpline, 1-877-SAMHSA7 (1-877-726-4727) and https://www.samhsa.gov Learn more about your ad choices. Visit megaphone.fm/adchoices

Subscribe to our channel:    / @optispan  Get Our Newsletter (It's Free): https://www.optispan.life/Dive into the future of longevity research with Dr. Ben Blue, CEO of Ora Biomedical. We explore how Ora's high-throughput "Wormbot" platform is conducting the world's largest unbiased search for longevity interventions, moving beyond the narrow focus on established pathways like mTOR.In this episode, we discuss:• The ambitious Million Molecule Challenge and why it could revolutionize the field.• Surprising discoveries already made, including molecules that outperform rapamycin.• Ora's strategic pivot to radiation resistance, with applications for astronauts, pilots, and human health.• How their data-driven approach is uncovering interventions for resilience against toxins and other stresses.• The journey from worm models to potential clinical trials and what's next for the company.Learn how Ora is scaling drug discovery to tackle aging and age-related diseases.https://orabiomedical.com/https://x.com/OraBiomedical  / ora-biomedical-inc  This video was produced by One Billion Media, an agency that specializes in YouTube virality for health brands and experts. Learn more about their work here:https://onebillionmedia.com/Timestamps00:00 – Intro01:13 – Welcome & Disclosure02:40 – Ora Biomedical & the Longevity Mission04:04 – How the Wormbot Was Born06:43 – Matt's Perspective on the Wormbot09:22 – Automating Lifespan Experiments at Scale12:29 – The Million Molecule Challenge15:03 – Success Stories from the Challenge16:10 – A Better mTOR Inhibitor Than Rapamycin19:05 – Ora's Molecule Beats Rapamycin20:08 – 60% Lifespan Extension Discovery24:03 – Ivermectin & Surprising Findings24:55 – From Longevity to Anti-Parasite Drugs31:09 – Hot Take: Discovery vs. Mechanism35:22 – The Million Molecule Challenge Database40:45 – Radiation Resistance: A New Focus44:57 – Space Travel & Longevity Medicine49:18 – Testing Resilience to Toxins & Stress56:54 – What Thousands of Tests Reveal About Aging Pathways01:00:41 – False Positives vs. False Negatives in Screening01:04:45 – Skin Health & Anti-Aging Potential01:07:59 – What's Next for Ora BiomedicalDISCLAIMER: The information provided on the Optispan podcast is intended solely for general educational purposes and is not meant to be, nor should it be construed as, personalized medical advice. No doctor-patient relationship is established by your use of this channel. The information and materials presented are for informational purposes only and are not a substitute for professional medical advice, diagnosis, or treatment. We strongly advise that you consult with a licensed healthcare professional for all matters concerning your health, especially before undertaking any changes based on content provided by this channel. The hosts and guests on this channel are not liable for any direct, indirect, or other damages or adverse effects that may arise from the application of the information discussed. Medical knowledge is constantly evolving; therefore, the information provided should be verified against current medical standards and practices.More places to find us:Twitter: https://x.com/Optispan_IncTwitter:   / mkaeberlein  Linkedin:   / optispan  Instagram:   / optispan_  TikTok:   / optispan  https://www.optispan.life/

In this episode of Molecule to Market, you'll go inside the outsourcing space of the global drug development sector with Dr. Fozia Saleem, Chief Executive Officer at Magnitude Biosciences. Your host, Raman Sehgal, speaks with Fozia about the pharmaceutical and biotechnology supply chain, including: How her early roles shaped her focus on applying science and innovation in a practical way The contrast between working in tobacco and vape R&D and traditional pharma research How a post-COVID reckoning led her to a CEO role at a university spin-out The commercial potential of worms, the WormGazer® technology platform, and why Magnitude Biosciences is far from a cookie-cutter CRO Fundraising, tripling the team, doubling lab space, and navigating the life of a scrappy CRO How the company is helping clients with novel therapies get better insights earlier and faster amid a tough market environment Dr. Fozia Saleem is the CEO of Magnitude Biosciences, a leading contract research organisation serving the pharmaceutical, health, and nutrition sectors to better understand the effects of drugs and nutraceuticals on healthy ageing, longevity, and neurodegeneration. With more than 15 years of experience across the FMCG and pharmaceutical industries — including leadership roles at GSK, BAT, and Broughton — Fozia has led global product launches, driven high-growth commercial strategies, and delivered transformative organisational change. Beyond her role at Magnitude Biosciences, Fozia is a passionate advocate for women's leadership and inclusive innovation. She previously co-chaired The Lifted Project – Newcastle Board, supporting high-growth female founders, and was named on the We Are Power Future List 2024 in recognition of her business leadership.   Molecule to Market is sponsored by Bora Pharmaceuticals and Charles River Laboratories, and supported by Lead Candidate. Please subscribe, tell your industry colleagues, and help us celebrate the value of the global life science outsourcing space. We'd also appreciate a positive rating!

Hydrogen tablets will revolutionise medicine within five years: mark my words. We're talking about delivering medications, mitigating concussive injuries, repairing the endothelium, enhancing GLP-1 secretion, and restoring true redox homeostasis through your body's own NRF2 pathway. What would healthcare look like if we prioritised cellular homeostasis over symptom suppression? CLICK HERE TO BECOME GARYS VIP!: https://bit.ly/4ai0Xwg Thank you to our partners H2TABS: “ULTIMATE10” FOR 10% OFF: https://bit.ly/4hMNdgg BODYHEALTH: “ULTIMATE20” FOR 20% OFF: http://bit.ly/4e5IjsV BAJA GOLD: "ULTIMATE10" FOR 10% OFF: https://bit.ly/3WSBqUa COLD LIFE: THE ULTIMATE HUMAN PLUNGE: https://bit.ly/4eULUKp WHOOP: JOIN AND GET 1 FREE MONTH!: https://bit.ly/3VQ0nzW AION: “ULTIMATE10” FOR 10% OFF: https://bit.ly/4h6KHAD A-GAME: “ULTIMATE15” FOR 15% OFF: http://bit.ly/4kek1ij CARAWAY: “ULTIMATE” FOR 10% OFF: https://bit.ly/3Q1VmkC HEALF: 10% OFF YOUR ORDER: https://bit.ly/41HJg6S RHO NUTRITION: “ULTIMATE15” FOR 15% OFF: https://bit.ly/44fFza0 GOPUFF: GET YOUR FAVORITE SNACK!: https://bit.ly/4obIFDC GENETIC METHYLATION TEST (UK ONLY): https://bit.ly/48QJJrk GENETIC TEST (USA ONLY): ⁠https://bit.ly/3Yg1Uk9 Watch  the “Ultimate Human Podcast” every Tuesday & Thursday at 9AM EST: YouTube: https://bit.ly/3RPQYX8 Podcasts: https://bit.ly/3RQftU0 Connect with Gary Brecka Instagram: https://bit.ly/3RPpnFs TikTok: https://bit.ly/4coJ8fo X: https://bit.ly/3Opc8tf Facebook: https://bit.ly/464VA1H LinkedIn: https://bit.ly/4hH7Ri2 Website: https://bit.ly/4eLDbdU Merch: https://bit.ly/4aBpOM1 Newsletter: https://bit.ly/47ejrws Ask Gary: https://bit.ly/3PEAJuG Timestamps 00:00 Intro of Show 02:06 Hydrogen Gas Definition 04:30 What is Redox Homeostasis? 05:09 The Power of Hydrogen Gas 07:17 Oxidative Balance is the Goal The Ultimate Human with Gary Brecka Podcast is for general informational purposes only and does not constitute the practice of medicine, nursing or other professional health care services, including the giving of medical advice, and no doctor/patient relationship is formed. The use of information on this podcast or materials linked from this podcast is at the user's own risk. The Content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard or delay in obtaining medical advice for any medical condition they may have and should seek the assistance of their health care professionals for any such conditions. Learn more about your ad choices. Visit megaphone.fm/adchoices

What if one of the most powerful tools for repair, resilience, and longevity isn't a drug or a device—but the smallest molecule in the universe? In this episode of Metabolic Matters, Dr. Nasha Winters sits down with Matt (Mateo) Johnson, founder of Axiom H2, to explore the science and clinical potential of molecular hydrogen therapy.A former competitive athlete turned hydrogen specialist, Mateo has spent over a decade advancing medical-grade hydrogen technology, working with aerospace-level European R&D engineers to create some of the most precise, stable, and effective hydrogen delivery systems in the world.Together, they unpack the real science of hydrogen:• Why molecular hydrogen acts as a selective antioxidant• How its tiny size allows it to reach the mitochondria, brain, and DNA• The difference between hydrogen, hydrogen-rich water & Brown's gas• What current research reveals about oxidative stress, inflammation & mitochondrial dysfunction• Why hydrogen may support cognition, recovery, metabolic health, and long-COVID symptoms• How athletes, aging adults & those with chronic illness are using it safely and effectivelyIf you're curious about longevity, mitochondrial repair, cellular resilience, or cutting-edge wellness tech, this episode will expand your thinking about what hydrogen can do for human health.Learn more:Website: https://axiomh2.com/Instagram: http://instagram.com/hydrogenwarriorAbout Your HostI'm Dr. Nasha Winters, a global healthcare authority, best-selling author, and educator in the emerging field of integrative oncology and terrain-based cancer care. I host Metabolic Matters to explore the intersections between metabolism, medicine, and meaning.Subscribe, Share & ReviewIf you loved this conversation, please subscribe, rate, and share with a friend or clinician who needs to hear it.Support & Resources:Support Patient Grants: www.mtih.orgBook: The Metabolic Approach to CancerEducation Programs: www.metabolicregen.comSupplements: mitovida.comFollow on SocialsDr. Nasha on InstagramMetabolic Matters InstagramFacebookLinkedInTikTokYouTube Hosted on Acast. See acast.com/privacy for more information.

What if the future of fat loss and rapid recovery isn't a supplement, a workout program, or a diet plan, but a molecule your body already knows how to use? In this in-studio episode of the Metabolic Freedom Podcast, Ben Azadi sits down with Dr. Robert Bello, chiropractor and founder of Bio Thrive Peptides, for an eye-opening conversation about peptides like BPC-157 and TB-4 Frag. They explore how these compounds accelerate healing, support fat loss, restore joint function, boost hormone signaling, and reduce chronic inflammation safely and naturally. Dr. Bello breaks down the science behind peptide therapy, dosing strategies, sourcing standards, safety considerations, and red flags to avoid when purchasing peptides. Ben also shares his personal experience using The Wolverine Stack and the noticeable improvements in strength, recovery, and energy. If you're curious about peptides, longevity medicine, or solutions for chronic pain and inflammation, this episode is a must-listen.

Researchers believe it will be possible in the near future to build organisms from molecules with reversed structures. But a recent multi-disciplinary report suggest that creating such "mirror life" could lead to the end of all known life on earth. Jeff and Anthony discuss the report, and what it means for synthetic biology.LInk to the story: https://news.stanford.edu/stories/2024/12/potential-risks-of-mirror-lifeSupport the show and get bonus episodes, videos, Discord community access and more! http://patreon.com/wehaveconcernsJeff on Blue Sky: https://bsky.app/profile/jeffcannata.bsky.socialAnthony on Blue Sky: https://bsky.app/profile/acarboni.bsky.social

In this episode of Molecule to Market, you'll go inside the outsourcing space of the global drug development sector with: Andrew Gigax, Head of European Pharma Services M&A at William Blair Jennifer Chadwick, Founder and Principal at Jennifer Chadwick Consulting Sabina Ouimet Storrs, Principal at GHO Capital Partners Jason Foss, Head of Corporate Development at Bora Pharmaceuticals Your host, Raman Sehgal, speaks with his guests about the pharmaceutical and biotechnology ecosystem, including: How market stabilisation has been overtaken by the need for adaptation in times of uncertainty Disciplined and deeper M&A, with heightened scrutiny, buyer and seller disconnect, and a sharper focus on operational efficiency The growing demand for bispecifics, radiopharma, isotopes, and other emerging segments Why the “picks and shovels” that serve multiple modalities are where opportunity lies in pharma services Why the US remains the hottest market, and how AI adoption has mainly focused on workflow so far The shifts and trends that could reshape pharma services in the years ahead Molecule to Market is sponsored by Bora Pharma, Charles River and Lead Candidate, and supported by Lead Candidate. Please subscribe, tell your industry colleagues, and help us celebrate the value of the global life science outsourcing space. We'd also appreciate a positive rating!

Brad Kitchen, CEO of Element One Hydrogen and Critical Minerals (CSE: EONE) explains why hydrogen is completely changing the game when it comes to energy production and generation worldwide. Brad hones in on reasons why investors should be paying attention to this critical commodity, along with unpacking how Element One fits into the picture, with their exclusive hydrogen extraction technology and their projects in British Columbia and Alaska.Element One Hydrogen Website: https://e1-h2.comFollow Element One on X: https://x.com/Element_One_H2Disclaimer: Commodity Culture was compensated by Element One Hydrogen and Critical Minerals for producing this interview. Jesse Day is not a shareholder of Element One Hydrogen and Critical Minerals. Nothing contained in this video is to be construed as investment advice, do your own due diligence.Follow Jesse Day on X: https://x.com/jessebdayCommodity Culture on Youtube: https://youtube.com/c/CommodityCulture

Host Myrna Young welcomes Chris Burres, founder and chief scientist at MyVitalC, to explore the powerful potential of the ESS60 molecule in promoting longevity, wellness, and healthier aging. In this episode, they delve into how this molecule helps reduce oxidative stress, improve sleep quality, and combat migraines, all while operating uniquely within the mitochondria. Discover how breakthroughs in aging science are fueling transformational change and healthy strategies by enabling a pain-free, vibrant life. Gain insights into the antioxidant benefits of melatonin and innovative anti-aging strategies designed to enhance overall mental and physical health. Tune in to learn how you can support your wellness journey and embrace a life of vitality and renewal.Key Takeaways:ESS60 Molecule Benefits: Learn how ESS60 increases life expectancy by impacting oxidative stress, which plays a significant part in aging and related diseases.Improvement in Sleep: ESS60 profoundly affects sleep, revealing improved mental focus and energy throughout the day, which translates to better sleep at night.Mitochondrial Health: ESS60 acts within the mitochondria, helping reduce the negative effects of stressed mitochondria, crucial for overall health.Innovative Longevity Science: The episode highlights groundbreaking scientific advances powered by AI and information doubling, promising explorations towards achieving the terminal velocity of aging.Resources:My Vital C Website: myvitalc.com/transform $15 off first order Social Media: @myvitalc on various platformsThis Episode is sponsored by: AuraFrames - For a limited time, visit AuraFrames.com and get $45 off Aura's best-selling Carver Mat frames - by using promo code TRANSFORM at checkout. This exclusive Black Friday Cyber Monday deal is their best of the year, so order now before it ends! NativePath - Transform Your Skin, Hair, and Joints with Ancient Grass-Fed Collagen... Discover the life-changing effect of NativePath Collagen. RIGHT NOW, VISIT getnativepath.com/Transform FOR A SPECIAL BUNDLE DEAL AT A FRACTION OF THE RETAIL PRICE—BACKED BY A RISK-FREE 365-DAY GUARANTEETo advertise on our podcast, visit https://advertising.libsyn.com/TransformyourMindor email kriti@youngandprofiting.com See this video on The Transform Your Mind YouTube Channel https://www.youtube.com/@MyhelpsUs/videosTo see a transcripts of this audio as well as links to all the advertisers on the show page https://myhelps.us/Follow Transform Your Mind on Instagram https://www.instagram.com/myrnamyoung/Follow Transform Your mind on Facebookhttps://www.facebook.com/profile.php?id=100063738390977Please leave a rating and review on iTunes https://podcasts.apple.com/us/podcast/transform-your-mind/id1144973094 https://podcast.feedspot.com/personal_development_podcasts/

In this episode of Molecule to Market, your host Raman Sehgal discusses the pharmaceutical and biotechnology supply chain with Jean-François Brepson, Chief Executive Officer at PathoQuest. The conversation covers: Navigating 20 years of global leadership roles at Ipsen before moving from the corporate world into an investor-led entrepreneurial adventure The tough decision to refocus PathoQuest from diagnostics into a pure play CRO and pharma services business How a major strategic partnership transformed the company's trajectory and why Jean sees partnerships as a competitive weapon Riding the tailwind of the FDA's move away from animal testing and offering something game-changing in the CMC and GMP space The opportunities ahead for CROs and CDMOs in helping unlock the next wave of innovation Jean-François Brepson is a dedicated leader with deep experience in biotechnology and pharmaceuticals. Since becoming CEO of PathoQuest in 2015, he has built the company into a leading global CRO specializing in quality control of biological drugs using Next Generation Sequencing (NGS). Over his career, he has advanced innovative technologies and solutions that bridge scientific progress with real-world application. Prior to joining PathoQuest, Jean was Senior Vice President at Ipsen, where he led the global GI-Oncology and Endocrinology franchise.   Molecule to Market is sponsored by Bora Pharma, Charles River, and Lead Candidate. Please subscribe, tell your industry colleagues, and help us celebrate the value of the global life science outsourcing space. We'd also appreciate a positive rating!

What if you could block your sugar cravings at the source—and retrain your metabolism to crave health instead of glucose spikes?

In this episode of Molecule to Market, you'll go inside the outsourcing space of the global drug development sector with Jason Anderson, Chief Executive Officer at Ensera.   Your host, Raman Sehgal, speaks with Jason about the pharmaceutical and biotechnology supply chain, covering: Why he chose BASF over law school, and why McKinsey ultimately was not for him Moving from corporate life into a venture-backed polymer technology start-up before a major exit The search for a PE-backed specialty manufacturing role that led him to Ensera (formerly SteriPack) The importance of appreciating local knowledge when entering new markets Similarities and differences between outsourced services in pharma and medical devices How today's changes, pain, and uncertainty in the markets are creating opportunity Jason Anderson is CEO of Ensera (formerly SteriPack), a global contract design and manufacturing organization serving the pharmaceutical and medical device industries. He has led the company through a period of significant growth and change, including the integration of new design and product development capabilities with Ensera's core manufacturing services, and the launch of the new Ensera trading name.   Prior to Ensera, Jason held global business unit leadership roles at DJO/Enovis and at Saint-Gobain, overseeing businesses ranging from finished medical devices to customized, high-value components for biopharma and medical device industries. Earlier in his career, he held leadership roles at pre-revenue polymer technology start-up Novomer, at McKinsey and Company, and at BASF.   Jason has lived and worked in North America, Asia, and Europe. He holds a BS in Chemical Engineering from the University of Oklahoma and an MBA from Harvard Business School.   Molecule to Market is sponsored by Bora Pharma, Charles River, and Lead Candidate. Please subscribe, tell your industry colleagues, and help us celebrate the value of the global life science outsourcing space. We'd also appreciate a positive rating!

Curious about the molecule that's been dubbed the "molecule of energy?" Ever wonder how it impacts women's health, especially during midlife? Join us as we dive into the world of nitric oxide with Cathy Eason, Chief Science Officer at Berkeley Life. Discover why this often-overlooked molecule might be the missing piece in your health puzzle. What if your midlife vitality could be revitalized with a simple molecule? How does nitric oxide influence libido, heart health, and even skin vitality? Cathy debunks myths and uncovers the hidden connections between nitric oxide and hormones like estrogen and testosterone. Prepare to have your questions answered and your perspective transformed! Did you know your oral hygiene could impact your nitric oxide levels? How can leafy greens and beets support this essential molecule? Cathy shares practical tips on optimizing nitric oxide through diet, lifestyle, and even oral health. Get ready to uncover secrets that could enhance your health and vitality. In this episode, we uncover: How nitric oxide plays a crucial role in women's midlife health. Why nitrates from plants are better than those from cured meats. How nitric oxide influences hormones, libido, and emotional connectivity. Why oral hygiene is vital for nitric oxide production. How to optimize nitric oxide levels with diet and lifestyle changes. Tune in to this enlightening episode and unlock the secrets to a more vibrant midlife. Cathy will guide you through practical steps to harness the power of nitric oxide for a healthier, more energetic life!   Get 10% off your Berkeley Life Nitric Oxide products with coupon code HORMONE here.     Sponsors Order your LMNT electrolytes today and get a FREE 8 pack of samples! Plus try it risk free, they have a no-questions-asked refund policy – you don't even have to send it back! Bioptimzers Masszymes get 15% off at bioptimizers.com/hormone Sign for the FREE Menopause Doula Certification Webinar     Are you in peri or post menopause and looking to optimize your hormones and health? At Hormone Solutions, we offer telemedicine services and can prescribe in every U.S. state, as well as in British Columbia, Alberta, and Ontario in Canada.   Visit karenmartel.com to explore our comprehensive programs: Bioidentical Hormone Replacement Therapy Individualized Weight Loss Programs  Peptide Therapy for weight loss    Interested in our NEW Peptide Weight Loss Program? Join today and get all the details here.   Join our Women's Peri and Post Menopause Group Coaching Program, OnTrack, TODAY!   To our nursing audience members, our podcasts qualify for nursing CE @ RNegade.pro. Provide # CEP17654.   Your host: Karen Martel Certified Hormone Specialist, Transformational Nutrition Coach, & Weight Loss Expert   Karen's Facebook Karen's Instagram

In this episode, Chris Burris, founder and chief scientist at My Vital C, discusses his journey into longevity research, the discovery of the ESS-60 molecule, and its implications for health and wellness. He shares insights on the transition from industrial applications to the supplement industry, the importance of testimonials, and the mechanisms behind the molecule's effects on oxidative stress and inflammation. Chris also emphasizes the need for careful consideration when navigating the supplement market and offers practical tips for improving health and longevity.What we cover in this episode:How a Nobel Prize-winning molecule (ESS60) extended lifespan by 90% in animal studiesThe transition from industrial applications to health supplements driven by customer demand.The BOSS theory and how the ESS-60 molecule buffers oxidative stress.Smart ways to stack ESS60 with other longevity supplementsThe main drivers of aging and natural ways to slow them down.Common supplement scams and how to identify safe, high-quality products.The importance of sleep and its impact on overall health.Sponsors:Free Webinar to Heal Your Autoimmune Disease and Mystery Symptoms: https://www.naturalhealthrising.net/webinar EQUIP Prime Protein: https://www.equipfoods.com/NHR15 Save 15% off with code: NHR15Connect with Chris and MyVitalC:Instagram: https://www.instagram.com/myvitalcFacebook: https://www.facebook.com/myvitalcTikTok: https://www.tiktok.com/@myvitalcYouTube: https://www.youtube.com/@MyVitalC/videosLive Longer and Better book: https://amzn.to/48TKJuETry MyVitalC:Special discount for listeners: https://www.myvitalc.com/pages/nhr/?ref=nhrConnect with Rachel:Free Health Consultation with Rachel: ⁠⁠⁠⁠⁠https://www.naturalhealthrising.net/health-consultation⁠⁠⁠⁠⁠Free Webinar to Heal Your Autoimmune & Mystery Symptoms: ⁠⁠⁠⁠⁠https://www.naturalhealthrising.net/webinar⁠⁠⁠⁠⁠Free Energy Reboot Plan: ⁠⁠⁠⁠⁠https://www.naturalhealthrising.net/energy-reboot-plan⁠⁠⁠⁠⁠Website: ⁠⁠⁠⁠⁠https://naturalhealthrising.com/⁠⁠⁠⁠⁠Support this podcast: ⁠⁠⁠⁠⁠https://anchor.fm/rachel-smith11/support⁠⁠⁠

Join us in this episode as Dr. Daniela Tropea, Associate Professor of Molecular Psychiatry at Trinity College Dublin, explains how cutting-edge brain research is being transformed into real-world treatments for mental health and neurodevelopmental disorders. Dr. Tropea leads the Translational Neuroscience Laboratory at Trinity, where her research on growth factors and brain plasticity has reshaped our understanding of brain health. Her work on insulin-like growth factor 1 directly contributed to the development of Trofinetide — the first FDA-approved treatment for Rett Syndrome. As she works, she continues to inspire new therapies for conditions like Fragile X and Phelan-McDermid Syndromes… This discussion dives into: How neuroscience research impacts real medical treatments. The future of translational neuroscience and personalized mental health care. Why mentorship, diversity, and public outreach are vital for scientific progress. A renowned educator and global collaborator, Dr. Tropea has received multiple awards for innovation in teaching and mentorship, and is deeply committed to making science accessible. Want to learn more about her intriguing work? Visit her profile at Trinity College Dublin or follow her latest publications in neuroscience.

In this episode of Molecule to Market, you'll go inside the outsourcing space of the global drug development sector with our host Raman Sehgal, who discusses the themes and vibe of CPHI 2025 in Frankfurt.     Molecule to Market is also sponsored by Bora Pharma and Charles River, and supported by Lead Candidate. Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We'd also appreciate a positive rating!

Welcome back to The Integrative Health Podcast! In this episode, Dr. Jen Pfleghaar, DO, sits down with Chris Burres — founder and chief scientist at My Vital C — to explore a truly fascinating molecule that's been called a breakthrough for longevity and vitality: ESS60.Chris shares how this Nobel Prize–winning form of carbon (C60) was discovered, how it unexpectedly extended the lives of lab rats by 90%, and what new research is revealing about its potential to support mitochondrial health, energy, sleep, and inflammation balance.Dr. Jen and Chris break down how ESS60 works at the cellular level — acting as a Buffering Oxidative Stress System (BOSS) to protect the mitochondria from damage — and why this might be the missing link in modern health and longevity science.You'll also hear fascinating insights from clinical trials, user testimonials, and what makes My Vital C different from other supplements on the market.If you've ever wondered whether science has found a real “longevity molecule,” this episode is a must-listen.PODCAST: Thank you for listening please subscribe and share! Shop supplements: https://healthybydrjen.shop/CHECK OUT a list of my Favorite products here: https://www.healthybydrjen.com/drjenfavorites FOLLOW ME:Instagram :: https://www.instagram.com/integrativedrmom/Facebook :: https://www.facebook.com/integrativedrmomYouTube :: https://www.youtube.com/@integrativedrmom FTC: Some links included in this description might be affiliate links. If you purchase a product through one of them, I will receive a commission (at no additional cost to you). I truly appreciate your support of my channel. Thank you for watching! Video is not sponsored. DISCLAIMER: This podcast does not contain any medical or health related diagnosis or treatment advice. Content provided on this podcast is for informational purposes only. For any medical or health related advice, please consult with a physician or other healthcare professionals. Further, information about specific products or treatments within this podcast are not to diagnose, treat, cure or prevent disease.

Watch every episode ad-free & uncensored on Patreon: https://patreon.com/dannyjones Chris McCurdy is a pharmaceutical scientist and pharmacist whose research focuses on the design, synthesis and development of drugs to treat pain and drug abuse. His latest research investigates a naturally occurring molecule that may regulate an enzyme which helps produce the powerful psychedelic compound dimethyltryptamine, or DMT, in the body. SPONSORS https://expressvpn.com/dannyjones - Get up to 4 extra months free. https://mnniceethno.com/dj - Use code DJ22 for 22% off your first order. https://ver.so/danny - Use code DANNY for 15% off your order. https://whiterabbitenergy.com/?ref=DJP - Use code DJP for 20% off EPISODE LINKS https://pharmacy.ufl.edu/profile/mccurdy-christopher https://pubmed.ncbi.nlm.nih.gov/?term=McCurdy+CR&cauthor_id=33213215 FOLLOW DANNY JONES https://www.instagram.com/dannyjones https://twitter.com/jonesdanny OUTLINE 00:00 - The most hallucinogenic plant in existence 09:39 - Natural DMT in our bodies & schizophrenia 19:43 - Finding DMT in spinal fluid 27:06 - Endogenous tripping & transcendental meditation 37:26 - Placebo effect & treating cancer with the brain 47:08 - The flaw in the "healthcare equation" 57:18 - Why coca leaves should be legal 01:13:44 - Only 3 countries where coca leaves are legal 01:17:18 - Kratom's dangerous trajectory 01:29:15 - World's biggest kratom study 01:43:01 - 7 hydroxy products (7-OH) vs. kratom 01:47:12 - The drug with the deadliest withdrawal process 01:59:52 - Why ritalin shouldn't be prescribed to kids 02:07:46 - How Modafinil works 02:14:55 - The kanna plant 02:20:02 - FDA finds how much kratom leads to overdose 02:28:12 - Different strains of kratom leaf Learn more about your ad choices. Visit podcastchoices.com/adchoices

Send us a textThe episode features an urgent conversation with renowned nitric oxide biochemist Dr. Nathan Bryan, who explains why nitric oxide is the foundational molecule of health, connecting everything from cardiovascular function to Alzheimer's prevention.Dr. Bryan details how nitric oxide regulates blood flow, mobilizes stem cells, and controls mitochondrial energy production. He argues that the loss of nitric oxide production, often caused by the destruction of the oral microbiome (via antiseptic mouthwash and fluoride) and poor light environments, is the root cause of many chronic diseases. He explains his scientific approach to restoring nitric oxide with a patented lozenge, affirming his mission to develop therapeutic solutions that help patients get off prescription drugs, despite significant pushback.ResourcesUse discount code “Crawford” for 10% off your purchase at n101.com Products 528 Innovations Lasers NeuroSolution Full Spectrum CBD NeuroSolution Broad Spectrum CBD NeuroSolution StimPod STEMREGEN® Learn MoreFor more information, resources, and podcast episodes, visit https://tinyurl.com/3ppwdfpm

What if the key to slowing down aging, restoring energy, and feeling truly alive again came down to one powerful molecule inside your cells? In this episode of the Metabolic Freedom Podcast, Ben Azadi sits down with Harvard-trained NAD+ researcher Dr. Andrew Salzman to uncover the hidden role of NAD+—the molecule that fuels your metabolism, hormones, and overall vitality. Dr. Salzman breaks down why NAD+ levels drop as we age—and how that decline drives fatigue, inflammation, and hormonal chaos. You'll learn how to naturally restore your NAD+ through ketogenic eating, fasting, and smart supplementation, along with simple habits that can help you recharge from the inside out. This conversation blends science and soul—packed with practical takeaways, inspiring personal stories, and even a discussion on the power of gratitude in longevity. If you're ready to boost your energy, sharpen your mind, and age vibrantly, this is one episode you won't want to miss.

In this mind-expanding conversation, psychiatrist and author Daniel Lieberman unpacks the role of dopamine — the brain's molecule of motivation — and how it shapes nearly every aspect of our lives, from love and ambition to addiction and impulsive behavior. Drawing from his bestselling book *The Molecule of More*, Lieberman explains why we're wired to crave what's out of reach and why that craving often leads to restlessness, dissatisfaction, or destructive decisions. He contrasts dopamine's future-focused drive with the chemistry of the present moment, exploring how we mistake infatuation for love, sabotage long-term happiness, and continually chase “more” even when we have enough. Packed with science, stories, and sobering insights, this episode offers a framework for understanding your own behavior and building a more balanced relationship with desire itself. Hosted on Acast. See acast.com/privacy for more information.